(NASDAQ: TLPH) Talphera's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 18.36%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.19%.
Talphera's earnings in 2026 is -$15,076,000.On average, 5 Wall Street analysts forecast TLPH's earnings for 2026 to be -$11,824,140, with the lowest TLPH earnings forecast at -$12,208,243, and the highest TLPH earnings forecast at -$10,900,217. On average, 5 Wall Street analysts forecast TLPH's earnings for 2027 to be -$13,059,498, with the lowest TLPH earnings forecast at -$13,734,274, and the highest TLPH earnings forecast at -$10,900,217.
In 2028, TLPH is forecast to generate -$8,118,066 in earnings, with the lowest earnings forecast at -$9,664,859 and the highest earnings forecast at -$5,450,109.